返回 Agenda
OS15 The Additional Pharmacovigilance Plan: Role in Japan
Session Chair(s)
Yumiko Suzuki, PhD
Senior Director, PMS Affairs
Pfizer R&D Japan, Japan
Speaker(s)
Tetsuya Kanayama
Novartis Pharma K.K., Japan
Head, CDD3 CDD & Re-examination Clinical Development & Analytics
Kanami Sugimoto
Suzuken Co., Ltd., Japan
Ryo Nakajima, MS
AbbVie GK, Japan
Manager, Medical